Tobramycin for Inhalation ( DrugBank: Tobramycin )


1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis3

299. Cystic fibrosis


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00794586
(ClinicalTrials.gov)
November 200818/11/2008Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung InfectionA Phase 2, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Fosfomycin/Tobramycin for Inhalation in Patients With Cystic Fibrosis and Pseudomonas AeruginosaCystic FibrosisDrug: FTI, AZLI;Drug: Placebo, AZLIGilead SciencesNULLCompleted18 YearsN/ABoth120Phase 2United States
2NCT01400750
(ClinicalTrials.gov)
August 200118/7/2011Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic FibrosisProspective Randomized Trial Comparing Oral Ciproxin Plus Inhaled Colistin With Tobramycin for Inhalation for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis.Cystic FibrosisDrug: oral ciprofloxacin plus inhaled colistin;Drug: TOBIUniversitaire Ziekenhuizen LeuvenNULLCompletedN/A18 YearsBoth61Phase 4Belgium
3NCT00006280
(ClinicalTrials.gov)
February 200011/9/2000A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic FibrosisA Phase II Multicenter Randomized Trial of Tobramycin for Inhalation in Young Children With Cystic FibrosisCystic FibrosisDrug: Tobramycin for InhalationNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)National Center for Research Resources (NCRR)Completed6 Months5 YearsBoth98Phase 2United States